Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein‐IgG Associated Disease Compared to Multiple Sclerosis
ABSTRACT Background Little is known about cognitive outcomes in people with myelin oligodendrocyte glycoprotein‐IgG associated disease (pwMOGAD). While there are similarities between MOGAD and multiple sclerosis (MS), further evaluation is needed to establish the distinct cognitive trajectories for...
Saved in:
| Main Authors: | Eileen Galvani, Jeffrey A. Cohen, John T. Martin, Kunio Nakamura, Amy Kunchok, Rachel Galioto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Brain and Behavior |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brb3.70310 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Clinical and Radiologic Features of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOGAD) in the City of Sakarya, Türkiye
by: Saadet Sayan, et al.
Published: (2025-07-01) -
The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study
by: Jiafei Cheng, et al.
Published: (2025-03-01) -
Unmasking myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): CNS demyelination triggered by TNF-alpha Inhibition in a patient with ankylosing spondylitis
by: Sujatha Baddam, et al.
Published: (2025-05-01) -
Biomarkers for diagnosis and prognosis of myelin oligodendrocyte glycoprotein antibody-associated disease - review article
by: Tamang Sapana, et al.
Published: (2025-06-01) -
Targeted steroid delivery for myelin oligodendrocyte glycoprotein antibody-associated rare optic neuritis: Clinical outcome and review literature
by: Shweta Singh, et al.
Published: (2025-04-01)